Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$1.69 - $2.67 $419,387 - $662,581
-248,158 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$1.79 - $2.91 $2,491 - $4,050
-1,392 Reduced 0.56%
248,158 $496,000
Q4 2020

Feb 02, 2021

BUY
$1.07 - $2.0 $267,018 - $499,100
249,550 New
249,550 $472,000

Others Institutions Holding VBLT

About Vascular Biogenics Ltd.


  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.